Literature DB >> 21997577

Herpes zoster and postherpetic neuralgia surveillance using structured electronic data.

Michael Klompas1, Martin Kulldorff, Yury Vilk, Stephanie R Bialek, Rafael Harpaz.   

Abstract

OBJECTIVE: To develop electronic algorithms for rapid, automated surveillance for herpes zoster and postherpetic neuralgia (PHN) using codified electronic health data. PATIENTS AND METHODS: We attempted to identify every case of herpes zoster and PHN arising between January 1 and December 31, 2008, within the electronic medical record of a 560,000-patient ambulatory practice using an array of diagnosis codes; intervals between herpes zoster encounters; and prescriptions for analgesics, anticonvulsants, and antidepressants. We assessed the sensitivity and positive predictive value (PPV) of each screening criterion by medical record review and then integrated multiple criteria into combination algorithms to optimize sensitivity and PPV. We applied the optimized algorithms to the practice's historical data spanning January 1, 1996, to December 31, 2008, to assess for changes in the annual incidence of PHN.
RESULTS: The International Classification of Diseases, Ninth Revision, code 053 detected herpes zoster with 98% sensitivity and 93% PPV. A combination algorithm including diagnosis codes, visit intervals, and prescriptions detected PHN with 86% sensitivity and 78% PPV. Between 1996 and 2008, the age- and sex-adjusted annual incidence of PHN rose from 0.18 to 0.47 cases per 1000 patients, and the proportion of herpes zoster patients progressing to PHN rose from 5.4% to 17.6%.
CONCLUSION: Novel algorithms incorporating multiple streams of electronic health data can reasonably detect herpes zoster and PHN. These algorithms could facilitate meaningful public health surveillance using electronic health data. The incidence of PHN may be increasing.

Entities:  

Mesh:

Year:  2011        PMID: 21997577      PMCID: PMC3228613          DOI: 10.4065/mcp.2011.0305

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  30 in total

1.  Acute pain in herpes zoster and its impact on health-related quality of life.

Authors:  Jennifer Katz; Edith M Cooper; Robert R Walther; Eugene W Sweeney; Robert H Dworkin
Journal:  Clin Infect Dis       Date:  2004-07-19       Impact factor: 9.079

2.  Risk factors for postherpetic neuralgia.

Authors:  P W Choo; K Galil; J G Donahue; A M Walker; D Spiegelman; R Platt
Journal:  Arch Intern Med       Date:  1997-06-09

3.  Population-based study of herpes zoster and its sequelae.

Authors:  M W Ragozzino; L J Melton; L T Kurland; C P Chu; H O Perry
Journal:  Medicine (Baltimore)       Date:  1982-09       Impact factor: 1.889

4.  Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.

Authors:  Hung Fu Tseng; Ning Smith; Rafael Harpaz; Stephanie R Bialek; Lina S Sy; Steven J Jacobsen
Journal:  JAMA       Date:  2011-01-12       Impact factor: 56.272

5.  Missing clinical information during primary care visits.

Authors:  Peter C Smith; Rodrigo Araya-Guerra; Caroline Bublitz; Bennett Parnes; L Miriam Dickinson; Rebecca Van Vorst; John M Westfall; Wilson D Pace
Journal:  JAMA       Date:  2005-02-02       Impact factor: 56.272

6.  Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study.

Authors:  Sara L Thomas; Jeremy G Wheeler; Andrew J Hall
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

7.  Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory.

Authors:  Paul M Coplan; Kenneth Schmader; Alexander Nikas; Ivan S F Chan; Peter Choo; Myron J Levin; Gary Johnson; Mark Bauer; Heather M Williams; Karen M Kaplan; Harry A Guess; Michael N Oxman
Journal:  J Pain       Date:  2004-08       Impact factor: 5.820

Review 8.  What does epidemiology tell us about risk factors for herpes zoster?

Authors:  Sara L Thomas; Andrew J Hall
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

9.  Risk factors for postherpetic neuralgia in patients with herpes zoster.

Authors:  Beth F Jung; Robert W Johnson; David R J Griffin; Robert H Dworkin
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

10.  The epidemiology of varicella and its complications.

Authors:  P W Choo; J G Donahue; J E Manson; R Platt
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

View more
  42 in total

1.  Post-shingles neuralgia by any definition is painful, but is it PHN?

Authors:  Barbara P Yawn
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

2.  Integrating clinical practice and public health surveillance using electronic medical record systems.

Authors:  Michael Klompas; Jason McVetta; Ross Lazarus; Emma Eggleston; Gillian Haney; Benjamin A Kruskal; W Katherine Yih; Patricia Daly; Paul Oppedisano; Brianne Beagan; Michael Lee; Chaim Kirby; Dawn Heisey-Grove; Alfred DeMaria; Richard Platt
Journal:  Am J Public Health       Date:  2012-06       Impact factor: 9.308

3.  Trends in Nationwide Herpes Zoster Emergency Department Utilization From 2006 to 2013.

Authors:  Erica D Dommasch; Cara J Joyce; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2017-09-01       Impact factor: 10.282

4.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

5.  MDPHnet: secure, distributed sharing of electronic health record data for public health surveillance, evaluation, and planning.

Authors:  Joshua Vogel; Jeffrey S Brown; Thomas Land; Richard Platt; Michael Klompas
Journal:  Am J Public Health       Date:  2014-10-16       Impact factor: 9.308

6.  Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.

Authors:  Jae-Ki Choi; Sun Hee Park; Sanghyun Park; Su-Mi Choi; Si-Hyun Kim; Dong-Gun Lee; Jin-Hong Yoo; Jung-Hyun Choi; Jin Han Kang
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

7.  Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).

Authors:  María D Esteban-Vasallo; M Felicitas Domínguez-Berjón; Ruth Gil-Prieto; Jenaro Astray-Mochales; Angel Gil de Miguel
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

8.  Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.

Authors:  M D Long; C Martin; R S Sandler; M D Kappelman
Journal:  Aliment Pharmacol Ther       Date:  2012-12-13       Impact factor: 8.171

9.  Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.

Authors:  Bryant R England; Ted R Mikuls; Fenglong Xie; Shuo Yang; Lang Chen; Jeffrey R Curtis
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

10.  Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study.

Authors:  Durga S Borkar; Vivien M Tham; Elizabeth Esterberg; Kathryn J Ray; Aleli C Vinoya; John V Parker; Aileen Uchida; Nisha R Acharya
Journal:  Ophthalmology       Date:  2012-12-01       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.